(Q37299176)

19 August 2017

Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure (English)

1 reference

19 August 2017

0 references

0 references

0 references

0 references

1 reference

David E Lanfear

1

1 reference

19 August 2017

Reema Hasan

2

1 reference

19 August 2017

Ramesh C Gupta

3

1 reference

19 August 2017

Celeste Williams

4

1 reference

19 August 2017

Barbara Czerska

5

1 reference

19 August 2017

Cristina Tita

6

1 reference

19 August 2017

Rasha Bazari

7

1 reference

19 August 2017

Hani N Sabbah

8

1 reference

19 August 2017

29 July 2009

1 reference

Journal of Translational Medicine

19 August 2017

1 reference

19 August 2017

7

1 reference

19 August 2017

67

1 reference

Creative Commons Attribution 2.0 Generic

19 August 2017

start time

29 July 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Inotropes in the management of acute heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2724498

Anti-inflammatory and anti-apoptotic effects of levosimendan in decompensated heart failure: a novel mechanism of drug-induced improvement in contractile performance of the failing heart

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2724498

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2724498

Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2724498

Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2724498

Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2724498

Levosimendan therapy in decompensated chronic heart failure: favourable haemodynamic and neurohormonal effects but for how long?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2724498

Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2724498

Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2724498

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2724498

Randomized trial of phosphodiesterase inhibitors versus catecholamines in patients with acutely decompensated heart failure

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2724498

Amrinone suppresses the synthesis of tumor necrosis factor-alpha in human mononuclear cells.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2724498

Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure

2 September 2018

1 reference

12 December 2020

The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia

1 reference

12 December 2020

Serum levels of soluble form of Fas molecule in patients with congestive heart failure

1 reference

12 December 2020

Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure

1 reference

12 December 2020

Acute left ventricular unloading in dogs with chronic heart failure: continuous aortic flow augmentation versus intra-aortic balloon pumping

1 reference

12 December 2020

Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure

1 reference

12 December 2020

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

12 December 2020

Identifiers

DOI

10.1186/1479-5876-7-67

1 reference

Dimensions Publication ID

19 August 2017

0 references

1 reference

19 August 2017

PubMed publication ID

19640280

1 reference